Sets up notification channels for CloudWatch alarms using SNS topics and subscriptions. Always use this skill when configuring alarm notifications — it creates encrypted SNS topics, configures topic policies for CloudWatch access, sets up email/SMS/webhook subscriptions, and links alarms to notification actions with proper security controls.
日本語の概要は準備中です。原文の説明を表示しています。
aws/agent-toolkit-for-aws☆ 2,8772026年10月14日 更新
Establishes VPC peering connections between two VPCs for direct private network connectivity. Always use this skill when creating or managing VPC peering — it validates CIDR overlap, updates all route tables in both VPCs, configures DNS resolution, and provides security group guidance that are critical for correct connectivity.
日本語の概要は準備中です。原文の説明を表示しています。
aws/agent-toolkit-for-aws☆ 2,8772026年10月14日 更新
Creates and manages secrets in AWS Secrets Manager following security best practices. Always use this skill when creating secrets — it sets up dedicated KMS encryption keys, automatic rotation, least-privilege IAM policies, CloudTrail auditing, and lifecycle management that are essential for production-grade secret handling.
日本語の概要は準備中です。原文の説明を表示しています。
aws/agent-toolkit-for-aws☆ 2,8772026年10月14日 更新
Connects an existing AWS Lambda function to Amazon API Gateway by creating a REST or HTTP API with resource/method setup, Lambda proxy integration, permissions, and deployment. Always use this skill when connecting Lambda to API Gateway — it handles CORS, throttling, access logging, and production security hardening that are easy to miss.
日本語の概要は準備中です。原文の説明を表示しています。
aws/agent-toolkit-for-aws☆ 2,8772026年10月14日 更新
Use whenever datasets, cloud storage buckets, or data pipelines are mentioned — creating, saving, querying, listing, exploring, deleting, or processing data in S3, GCS, Azure Blob, or local storage. Also use when running any script that may create datasets as a side effect. Maintains a knowledge base at dc-knowledge/ (JSON + markdown). ALWAYS use this skill when the user creates a dataset, saves pipeline output, runs a data script, or references any storage bucket.
日本語の概要は準備中です。原文の説明を表示しています。
datachain-ai/datachain☆ 2,8262026年10月14日 更新
Org-grade attack-surface mapping: given a company's legal identity, discover its ENTIRE owned internet footprint — corporate family -> owned domains -> owned netblocks/ASN -> live assets — with attribution discipline, not just DNS breadth. The org-first attribution pyramid (legal entity -> LEI/registration -> corporate family -> owned domains -> owned netblocks/ASN -> live assets). Corporate-identity resolution via the GLEIF LEI API (legal name -> LEI, exact-LEI direct-children expansion, downward-only depth-capped BFS, NEVER a name re-resolution), SEC-EDGAR full-text search + Exhibit-21 subsidiary entity names, OpenCorporates entity corroboration, Wikidata SPARQL corporate graph (P856/P355/P749/P1830). Domain attribution via reverse-WHOIS (WhoisXML preview-then-purchase quota guard, SecurityTrails associated-domains — both paid), crt.sh O= certificate-transparency organization pivot (keyless), infrastructure correlation (shared NS/MX/SaaS-TXT, netblock membership, reverse-DNS PTR), and the independent-evidence combiner (1-prod(1-w_i), rule of three, OwnerTier NONE/WEAK/MODERATE/STRONG/CONFIRMED) — discover-only `related:` candidates are NEVER auto-scanned. Netblock/ASN attribution via org-first RIR queries (ARIN Whois-RWS org-handle search, RIPE DB organisation + inverse-org search) that recover 'dark netblocks' with no DNS link to the seed, ASN discovery (RIPEstat + BGPView union), the HYPERSCALER-SCOPE GUARD (never attribute a whole AWS/GCP/Azure/Cloudflare announced range to a tenant — keep only the seed-containing block, tag shared_hosting_cdn), and org-identity-seeded internet-scan-index queries (Shodan/Censys/ZoomEye/FOFA/BinaryEdge org: filters + an always-on keyless crt.sh fallback). Promote-to-scan triage ranks forgotten discover-only netblocks by remote-access exposure (gateway-vendor/KEV/control-plane/datastore port scoring) into an operator queue. Attribution confidence rubric + anti-patterns (namesake grafting via GLEIF name re-resolution, single-signal ownership, hyperscaler over-attribution, privacy-WHOIS pivot poisoning, RIR org-name collisions). Passive/keyless-first OSINT only — every paid-key dependency is enrichment on top of a keyless core, never a hard requirement. Use when mapping an organization's full corporate-family internet footprint, resolving a legal entity to its LEI/subsidiaries, discovering domains/netblocks/ASNs an org owns beyond its one seed domain, auditing M&A/shadow-IT sprawl, or scoping an engagement that starts from a company NAME rather than a domain.
日本語の概要は準備中です。原文の説明を表示しています。
elementalsouls/Claude-OSINT☆ 2,8182026年10月10日 更新
Names and rebrands an app clone so it is the user's own: name candidates with the trademark, domain, store and handle checks to run, a new palette checked for contrast, a logo brief, a voice guide, and a sweep tool that finds anything of the original left in the codebase. Use when the user says "name my app", "rebrand the clone", "make it mine", "pick a name and colours", "logo brief", "brand voice", "check for leftovers", or after /replica-entrepreneur. Always runs before /replica-launch.
日本語の概要は準備中です。原文の説明を表示しています。
Jakeschincariol/replica-skill☆ 2,6092026年10月3日 更新
Use this skill when designing, generating an MVP blueprint for, auditing, troubleshooting, refactoring, or explaining an agentic harness for any domain. Covers provider-neutral agent architecture for OpenAI, Anthropic, and OpenAI-compatible APIs: agent loops, tool design, record provenance, interactive presentation, user-memory lifecycles, environment-adaptive tools, speculative tool execution, late-bound capabilities, permissions, system prompts, planning, goals, always-on agents and durable runtime, adaptive agent teams, context compaction, memory, skills, MCP/external connectors, public-board communications, realtime voice agents, hardware agents and board deployment, self-refining recursive harnesses, programmable context, continual refinement, observability, evals, prompt caching, agent-legible environments, feedback loops, and safety.
日本語の概要は準備中です。原文の説明を表示しています。
DenisSergeevitch/agents-best-practices☆ 2,3822026年10月14日 更新
Lark/Feishu channel output rules. Always active in Lark conversations.
日本語の概要は準備中です。原文の説明を表示しています。
larksuite/openclaw-lark☆ 2,3802026年7月22日 更新
Use Crabbox from macOS, Linux, or native Windows controllers to run OpenClaw Windows node builds, tests, and targeted proof on remote native Windows or WSL2 hosts, including Azure or brokered AWS leases and static SSH hosts. Use when remote Windows validation is needed or the user asks for Crabbox validation. Always report the actual provider, lease id, run URL, command, and result.
日本語の概要は準備中です。原文の説明を表示しています。
openclaw/openclaw-windows-node☆ 2,1502026年10月14日 更新
Use when about to claim work is complete, fixed, or passing, before committing or creating PRs - requires running verification commands and confirming output before making any success claims; evidence before assertions always
日本語の概要は準備中です。原文の説明を表示しています。
openakita/openakita☆ 1,9972026年9月24日 更新
Manage Obsidian vaults with full support for Obsidian Flavored Markdown — wikilinks, embeds, callouts, YAML properties, Dataview queries, Canvas, and Bases. Organize notes using MOCs (Maps of Content), atomic note principles, and consistent folder/tag taxonomies. Always ask the user where to save before creating notes.
日本語の概要は準備中です。原文の説明を表示しています。
openakita/openakita☆ 1,9972026年9月24日 更新
Automate Gmail tasks via Rube MCP (Composio): send/reply, search, labels, drafts, attachments. Always search tools first for current schemas.
日本語の概要は準備中です。原文の説明を表示しています。
openakita/openakita☆ 1,9972026年9月24日 更新
Extracts clinical trial baseline data (study, region, participants, etc.) from article text or PMID. Checks PubMed for metadata; always falls back to LLM extraction for full details.
日本語の概要は準備中です。原文の説明を表示しています。
aipoch/medical-research-skills☆ 1,9542026年9月17日 更新
Compares multiple study-route options for the same biomedical research question and recommends one primary plan, while explicitly explaining why alternative routes are secondary, premature, weaker, or dependency-heavy. Always use this skill when the user already has a reasonably defined question but is unsure which main study route should anchor the project. Focus on plan comparison, route selection, dependency awareness, and primary-plan justification rather than full protocol drafting.
日本語の概要は準備中です。原文の説明を表示しています。
aipoch/medical-research-skills☆ 1,9542026年9月17日 更新
Generates complete process-related diagnostic biomarker bioinformatics research designs from a user-provided disease context, gene-family or pathway theme, and validation direction. Use when a study centers on process-related genes, DEG and WGCNA integration, machine-learning feature selection, nomogram-based diagnostic modeling, immune infiltration, regulatory-network analysis, and optional external or experimental validation. Covers five study patterns (process-DEG discovery, co-expression-module integration, machine-learning biomarker selection, diagnostic model/nomogram workflow, immune-regulatory interpretation and validation) and always outputs Lite / Standard / Advanced / Publication+ with a recommended primary plan, stepwise workflow, figure plan, validation hierarchy, minimal executable version, publication upgrade path, and strictly verified literature retrieval.
日本語の概要は準備中です。原文の説明を表示しています。
aipoch/medical-research-skills☆ 1,9542026年9月17日 更新
Designs a realistic, execution-aware biomedical study version under explicit constraints of samples, time, budget, data access, lab capacity, team skill, and validation resources. Always use this skill when the user has a real study idea, a candidate route, or a partially framed project but cannot assume ideal conditions. If critical feasibility inputs are missing, first clarify what resources are currently available, what resources may be obtainable, and what resources are realistically unavailable. Do not invent access, capabilities, collaborations, or validation resources. Focus first on feasibility-constrained study framing, route narrowing, dependency control, and minimum viable study design.
日本語の概要は準備中です。原文の説明を表示しています。
aipoch/medical-research-skills☆ 1,9542026年9月17日 更新
Generates complete conventional non-oncology diagnostic machine-learning research designs from a user-provided disease context, optional mechanism theme, and validation direction. Use when a study centers on disease-vs-control transcriptome comparison, optional mechanism-gene restriction, feature shrinkage, diagnostic model construction, ROC / calibration / DCA evaluation, interpretation layers, and orthogonal validation. Covers five study patterns and always outputs Lite / Standard / Advanced / Publication+ with a recommended primary plan, stepwise workflow, figure plan, validation hierarchy, minimal executable version, publication upgrade path, and strictly verified literature retrieval.
日本語の概要は準備中です。原文の説明を表示しています。
aipoch/medical-research-skills☆ 1,9542026年9月17日 更新
Matches a user’s biomedical research direction, disease problem, study aim, data modality, and resource constraints to the most relevant recent algorithms and method papers. Always search real recent algorithm literature first, prioritize the last 12 months, expand to 1–3 years only when needed, and add canonical baselines only when necessary. Every formal algorithm recommendation must include the verified primary method paper, plus published downstream papers that actually cite/use the algorithm when such papers are found, with DOI when available. Never fabricate papers, algorithm names, authors, journals, years, DOI, PMID, links, or benchmark claims. If no directly verified algorithm paper is found, say so explicitly.
日本語の概要は準備中です。原文の説明を表示しています。
aipoch/medical-research-skills☆ 1,9542026年9月17日 更新
Designs primary, secondary, and exploratory endpoints for biomedical and clinical research protocols. Always use this skill when a user needs to translate study aims into operational endpoint definitions with event rules, assessment timing, composite logic, interpretability, and protocol-stage auditability. Focus on endpoint precision, feasibility, clinical meaning, ambiguity reduction, and implementation readiness rather than generic study design advice.
日本語の概要は準備中です。原文の説明を表示しています。
aipoch/medical-research-skills☆ 1,9542026年9月17日 更新
Designs retrospective or prospective clinical cohort study protocols for biomedical and clinical research. Always use this skill when the user needs a cohort-based study plan rather than a general study idea, evidence summary, or mechanistic experiment design. Focus on cohort appropriateness, enrollment logic, baseline time-zero definition, follow-up structure, endpoint definition, variable collection, confounding control, and a coherent primary statistical analysis line. Do not invent data availability, follow-up completeness, outcome ascertainment quality, sample size adequacy, or causal interpretability.
日本語の概要は準備中です。原文の説明を表示しています。
aipoch/medical-research-skills☆ 1,9542026年9月17日 更新
Generates complete conventional single-gene oncology research designs from a user-provided cancer context, target gene, and validation direction. Use when a study centers on a fixed candidate gene and needs expression, prognosis, clinicopathologic association, functional interpretation, immune context, genomic or epigenetic context, optional drug-response hypotheses, and orthogonal validation. Covers five study patterns and always outputs Lite / Standard / Advanced / Publication+ with a recommended primary plan, stepwise workflow, figure plan, validation hierarchy, minimal executable version, publication upgrade path, and strictly verified literature retrieval.
日本語の概要は準備中です。原文の説明を表示しています。
aipoch/medical-research-skills☆ 1,9542026年9月17日 更新
Designs studies for predicting treatment response or resistance in biomedical and clinical research. Always use this skill when the user needs a treatment-response or resistance prediction study blueprint rather than a prognostic biomarker protocol, diagnostic test design, causal treatment-effect estimation, or a completed manuscript. Focus on responder definition, treatment context, baseline comparability, feature integration strategy, model development logic, validation architecture, and interpretation boundaries. Do not invent response rates, cohort size, assay readiness, regimen uniformity, literature support, or validation access.
日本語の概要は準備中です。原文の説明を表示しています。
aipoch/medical-research-skills☆ 1,9542026年9月17日 更新
Plans confounder control, variable adjustment logic, and bias mitigation strategies at the protocol stage for clinical, epidemiologic, translational, observational, and biomarker studies. Always use this skill when a user needs to identify major confounders, decide which variables should or should not be adjusted for, compare matching/stratification/weighting approaches, anticipate selection or measurement bias, or pressure-test a study design before execution. Focus on bias sensing, causal structure awareness, variable-role classification, and critical design review rather than generic statistical advice.
日本語の概要は準備中です。原文の説明を表示しています。
aipoch/medical-research-skills☆ 1,9542026年9月17日 更新